Skip to main content

Table 1 Patient demographics and baseline characteristics for study samples ≤5 years old

From: Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma

Demographic Cases (N = 335)
Ethnicity  
 African American 4.8%
 Caucasian 39.7%
 Other 8.4%
 Unknown 47.2%
Age at surgery, years  
 ≤65 25.1%
 >65 74.9%
Sex  
 Female 27.8%
 Male 72.2%
Histology  
 Non-urothelial carcinomaa 3.3%
 Urothelial carcinoma 97.6%
Stage  
 0a 10.1%
 I 13.7%
 II 37.0%
 III 31.0%
 IIIB 0.3%
 IV 7.8%
Grade  
 High 77.7%
 Low 22.1%
 Unknown 0.3%
Sample type  
 Biopsy 0.3%
 Cystectomy 29.2%
 TURBT 69.6%
 Unknown 0.9%
  1. a Non-urothelial bladder cancer samples included in the analysis are further defined in Additional file 1
  2. TURBT transurethral resection of bladder tumor